MOJ
eISSN: 2379-6162
Submit manuscript...
Case Report Volume 12 Issue 3
Biliary pseudolithiasis induced by Ceftriaxone in pediatric patient treated in Cape Verde: case presentation
Francesco De Martini
Accademia Nazionale dei Lincei, Fondazione Università Sapienza, Italy
Received: November 19, 2024 | Published: December 27, 2024
Citation: Fuentes JC, Oliveros MAS. Biliary pseudolithiasis induced by Ceftriaxone in pediatric patient treated in Cape Verde: case presentation. MOJ Surgery. 2024;12(3):137-139. DOI: 10.15406/mojs.2024.12.00281
Abstract
Introduction: Ceftriaxone, a third generation cephalosporin, has become a frequently used antibiotic in pediatric patients with severe infections due to its pharmacological characteristics: broad spectrum, but in known its association with the occurrence of vesicular pseudolithiasis. The objective of this article is to present a case of Ceftriaxoneinduced biliary pseudolithiasis in a pediatric patient with a diagnostic approach that takes into consideration the combination of clinical-imaging methods. Case presentation: We present a clinical case of a healthy 9-year-old school boy who experienced non-specific abdominal pain for 11 days and was evaluated at Batista de Sousa Hospital. São Vicente Island, Cape Verde. The mother refers that she has presented unquantified febrile sensation. The clinical-imaging findings suggest appendicular plastron, for which an antibiotic plan with Ceftriaxone is decided. On the 14th day of the administration of Ceftriaxone she added constant pain in the right hypochondrium, so a diagnosis of Ceftriaxone-induced biliary pseudolithiasis was made. Conclusion: The combination of the clinical-imaging methods pave the way for an accurate diagnosis of Ceftriaxone-induced biliary lithiasis disease in children under the premise that this drug should be used with caution.
Keywords: ceftriaxone, biliary pseudolithiasis; biliary lithiasis, imaging
©2024 Fuentes. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.